ArticleEClinicalMedicine2021

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Jesper D Gunst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.